Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
about
Bioavailability enhancers of herbal origin: an overviewLoading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterolsDrug delivery systems, CNS protection, and the blood brain barrierExploring the influence of carbon nanoparticles on the formation of β-sheet-rich oligomers of IAPP₂₂₋₂₈ peptide by molecular dynamics simulation.Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer's disease: pharmaceutical, biological, and toxicological studies.Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer's disease models.Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease.SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.Methods for the In Vitro Characterization of Nanomedicines-Biological Component Interaction.Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.Intranasal therapeutic strategies for management of Alzheimer's disease.Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review.Nanomedicine for the treatment of Alzheimer's disease.Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood-brain barrier model.Improving drug delivery technology for treating neurodegenerative diseases.Co-encapsulation of Nigella sativa oil and plasmid DNA for enhanced gene therapy of Alzheimer's disease.Neuroprotective Effects of Castanea sativa Mill. Bark Extract in Human Neuroblastoma Cells Subjected to Oxidative Stress.Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders.Polyphenols Beyond Barriers: A Glimpse into the Brain.Cellular uptake of Nigella sativa oil-PLGA microparticle by PC-12 cell line.Antibody-conjugated, dual-modal, near-infrared fluorescent iron oxide nanoparticles for antiamyloidgenic activity and specific detection of amyloid-β fibrils.Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases.Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles.Castanea sativa Mill. Bark Extract Protects U-373 MG Cells and Rat Brain Slices Against Ischemia and Reperfusion Injury.Neuroprotective effects of three different sizes nanochelating based nano complexes in MPP(+) induced neurotoxicity.Phytol-loaded PLGA nanoparticle as a modulator of Alzheimer's toxic Aβ peptide aggregation and fibrillation associated with impaired neuronal cell function.In Vitro Modulation of TrkB Receptor Signaling upon Sequential Delivery of Curcumin-DHA Loaded Carriers Towards Promoting Neuronal Survival.Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for improved antioxidant and antidepressant-like activity.Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery.Polyglycerol-Based Copper Chelators for the Transport and Release of Copper Ions in Biological Environments.Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease.Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease ManagementPhyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer's Disease: Present Status and Future Opportunities
P2860
Q24631494-75D6BFDD-E8B0-4909-ABEC-4BC19A5F104EQ28538558-87EB8E0F-E0B5-44B1-894B-30C96B5F2921Q30432845-F7D24748-F82C-4C8F-83DC-F56C5114D994Q34766637-0637C067-6852-40A0-9C82-1DC08A8638F4Q36015934-5E1E87AE-0784-4E2F-A49F-9FAB914DAB78Q36247082-A8B971D5-8835-4361-9F51-AE70AC5B75C3Q36571755-4AB0632D-85CD-416D-94A0-46ABE710252AQ36710294-80435B66-1D50-4D60-B31F-CA3D80D698F4Q37731267-E3D41C7B-7B13-4395-98CB-8DFFB77ACA8DQ37948993-3F6FC0A7-4106-4A18-9F4D-A302BB152A98Q38176935-C04730DA-3E6F-46A2-BD63-F7E4AA02D1E7Q38372996-65C0D1CF-053A-4805-A30B-4FAB9D831BD4Q38451932-A1369560-F795-4743-BEF7-8BBC0F802C28Q38647131-22DF7662-80CE-4E78-B34C-887B7B556349Q38769989-02552A92-87CC-482B-BFD9-56BA15970F10Q38785933-0924331A-41C2-4B8B-8BBA-B2ACFA8B6798Q38846525-9F599699-4586-41DF-B5B5-5283259DBEECQ38857113-783CEC86-48CB-4086-B58F-46EE6D59894AQ38991608-B4638E2C-9EA5-41D6-A40E-18D7A5AE1522Q39008600-6091C93A-F342-44DC-B1DE-7219AFC4D11DQ39066716-63A8DD47-DE3A-497B-B68A-0918B38DD08FQ40789506-AC0770C8-4E6F-439D-9BB5-B96C0EA576F1Q41859836-253B6948-747C-479A-8192-538B759E43A2Q46478216-BB9A1680-0F55-4B6A-ADA5-17BA99806F53Q46806558-BA96C061-48F3-455B-AA58-FD6EBDA2664CQ47566506-C904D285-4104-40D1-9F51-43A043DA9CD4Q48136178-6B9F458E-17B9-409A-A9DB-D225F41FBFC7Q48284169-03DB1F7C-CD35-4D27-8C3C-0C5FB5CE7F3BQ52148908-071C6523-F026-4549-B70B-E74D4673A582Q52859832-06619DFA-2191-4E4C-857E-9E3B31222888Q55456183-73AC075D-CB1E-4692-B7D4-56711DD0A948Q57169956-5065650F-A8B1-4CA9-AD85-23FE12A48D71Q58571824-51674323-1536-4108-B9DB-0AB0A31FBBE2
P2860
Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
@en
Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
@nl
type
label
Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
@en
Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
@nl
prefLabel
Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
@en
Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
@nl
P2093
P1476
Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
@en
P2093
Charles Ramassamy
Jasjeet Kaur Sahni
Sihem Doggui
P304
P356
10.1016/J.JCONREL.2010.11.033
P407
P577
2010-12-04T00:00:00Z